Literature DB >> 33666173

Sequential perturbations to mouse corticogenesis following in utero maternal immune activation.

Cesar P Canales1, Myka L Estes1, Karol Cichewicz1, A Kimberley McAllister1, Alex S Nord1, Kartik Angara2, John Paul Aboubechara1, Scott Cameron1, Kathryn Prendergast1, Linda Su-Feher1, Iva Zdilar1, Ellie J Kreun1, Emma C Connolly1, Jin Myeong Seo1, Jack B Goon1, Kathleen Farrelly1, Tyler W Stradleigh1, Deborah van der List1, Lori Haapanen3, Judy Van de Water3, Daniel Vogt2.   

Abstract

In utero exposure to maternal immune activation (MIA) is an environmental risk factor for neurodevelopmental and neuropsychiatric disorders. Animal models provide an opportunity to identify mechanisms driving neuropathology associated with MIA. We performed time-course transcriptional profiling of mouse cortical development following induced MIA via poly(I:C) injection at E12.5. MIA-driven transcriptional changes were validated via protein analysis, and parallel perturbations to cortical neuroanatomy were identified via imaging. MIA-induced acute upregulation of genes associated with hypoxia, immune signaling, and angiogenesis, by 6 hr following exposure. This acute response was followed by changes in proliferation, neuronal and glial specification, and cortical lamination that emerged at E14.5 and peaked at E17.5. Decreased numbers of proliferative cells in germinal zones and alterations in neuronal and glial populations were identified in the MIA-exposed cortex. Overall, paired transcriptomic and neuroanatomical characterization revealed a sequence of perturbations to corticogenesis driven by mid-gestational MIA.
© 2021, Canales et al.

Entities:  

Keywords:  MIA; RNA-Seq; WGCNA; brain development; genetics; genomics; mouse; neuroscience; transcriptomic

Mesh:

Substances:

Year:  2021        PMID: 33666173      PMCID: PMC7979158          DOI: 10.7554/eLife.60100

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.713


  83 in total

1.  RSeQC: quality control of RNA-seq experiments.

Authors:  Liguo Wang; Shengqin Wang; Wei Li
Journal:  Bioinformatics       Date:  2012-06-27       Impact factor: 6.937

2.  SOX9 induces and maintains neural stem cells.

Authors:  Charlotte E Scott; Sarah L Wynn; Abdul Sesay; Catarina Cruz; Martin Cheung; Maria-Victoria Gomez Gaviro; Sarah Booth; Bo Gao; Kathryn S E Cheah; Robin Lovell-Badge; James Briscoe
Journal:  Nat Neurosci       Date:  2010-10       Impact factor: 24.884

3.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

4.  Sequentially acting SOX proteins orchestrate astrocyte- and oligodendrocyte-specific gene expression.

Authors:  Susanne Klum; Cécile Zaouter; Zhanna Alekseenko; Åsa K Björklund; Daniel W Hagey; Johan Ericson; Jonas Muhr; Maria Bergsland
Journal:  EMBO Rep       Date:  2018-08-30       Impact factor: 8.807

5.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

6.  Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation.

Authors:  M J Hendzel; Y Wei; M A Mancini; A Van Hooser; T Ranalli; B R Brinkley; D P Bazett-Jones; C D Allis
Journal:  Chromosoma       Date:  1997-11       Impact factor: 4.316

7.  Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt.

Authors:  Steffen Durinck; Paul T Spellman; Ewan Birney; Wolfgang Huber
Journal:  Nat Protoc       Date:  2009-07-23       Impact factor: 13.491

8.  Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring.

Authors:  Limin Shi; S Hossein Fatemi; Robert W Sidwell; Paul H Patterson
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

9.  Novel PCR assay for determining the genetic sex of mice.

Authors:  L McFarlane; V Truong; J S Palmer; D Wilhelm
Journal:  Sex Dev       Date:  2013-04-04       Impact factor: 1.824

10.  The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring.

Authors:  Gloria B Choi; Yeong S Yim; Helen Wong; Sangdoo Kim; Hyunju Kim; Sangwon V Kim; Charles A Hoeffer; Dan R Littman; Jun R Huh
Journal:  Science       Date:  2016-01-28       Impact factor: 47.728

View more
  4 in total

Review 1.  Maternal and Adult Interleukin-17A Exposure and Autism Spectrum Disorder.

Authors:  Masashi Fujitani; Hisao Miyajima; Yoshinori Otani; Xinlang Liu
Journal:  Front Psychiatry       Date:  2022-02-08       Impact factor: 4.157

2.  Differential effects of early or late exposure to prenatal maternal immune activation on mouse embryonic neurodevelopment.

Authors:  Elisa Guma; Maude Bordeleau; Fernando González Ibáñez; Katherine Picard; Emily Snook; Gabriel Desrosiers-Grégoire; Shoshana Spring; Jason P Lerch; Brian J Nieman; Gabriel A Devenyi; Marie-Eve Tremblay; M Mallar Chakravarty
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-14       Impact factor: 12.779

3.  Resveratrol Prevents Cytoarchitectural and Interneuronal Alterations in the Valproic Acid Rat Model of Autism.

Authors:  Júlio Santos-Terra; Iohanna Deckmann; Giovanna Carello-Collar; Gustavo Della-Flora Nunes; Guilherme Bauer-Negrini; Gustavo Brum Schwingel; Mellanie Fontes-Dutra; Rudimar Riesgo; Carmem Gottfried
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

4.  Krüppel-like Transcription Factor 7 Is a Causal Gene in Autism Development.

Authors:  Hui Tian; Shupei Qiao; Yufang Zhao; Xiyun Jin; Cao Wang; Ruiqi Wang; Yilin Wang; Yanwen Jiao; Ying Liu; Bosong Zhang; Jiaming Jin; Yue Chen; Qinghua Jiang; Weiming Tian
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.